COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,283 Articles (22,759 medRxiv, 8,524 bioRxiv)

Most recent first Previous |  Page 1984: Articles 19831-19840  | Next

Public Preferences for Social Distancing Behaviors to Mitigate the Spread of COVID-19: A Discrete Choice Experiment
Eshun-Wilson, I., Mody, A., McKay, V., Hlatshwayo, M., Bradley, C., Thompson, V., Glidden, D., Geng, E. H.
10.1101/2020.12.12.20248103 — Posted: 2020-12-14
A rapid, high-sensitivity SARS-CoV-2 nucleocapsid immunoassay to aid diagnosis of acute COVID-19 at the point of care
Drain, P. K., Ampajwala, M., Chappel, C., Gvozden, A. B., Hoppers, M., Wang, M., Rosen, R., Young, S., Zissman, E., Montano, M.
10.1101/2020.12.11.20238410 — Posted: 2020-12-14
Decay of Fc-dependent antibody functions after mild to moderate COVID-19
Lee, W. S., Selva, K. J., Davis, S. K., Wines, B. D., Reynaldi, A., Esterbauer, R., Kelly, H. G., Haycroft, E. R., Tan, H.-X., Juno, J. A., Wheatley, A. K., Hogarth, P. M., Cromer, D., Davenport, M. P., Chung, A. W., Kent, S. J.
10.1101/2020.12.13.20248143 — Posted: 2020-12-14
Human Safety, Tolerability, and Pharmacokinetics of a Novel Broad-Spectrum Oral Antiviral Compound, Molnupiravir, with Activity Against SARS-CoV-2
Painter, W. P., Holman, W., Bush, J. A., Almazedi, F., Malik, H., Eraut, N. C. J. E., Morin, M. J., Szewczyk, L. J., Painter, G. R.
10.1101/2020.12.10.20235747 — Posted: 2020-12-14
Predicting mortality in SARS-COV-2 (COVID-19) positive patients in the inpatient setting using a Novel Deep Neural Network
Naseem, M., Arshad, H., Hashimi, S. A., Irfan, F., Ahmed, F. S.
10.1101/2020.12.13.20247254 — Posted: 2020-12-14
Excess mortality during the first ten months of COVID-19 epidemic at Jakarta, Indonesia
Elyazar, I. R., Surendra, H., Ekawati, L., Djaafara, B. A., Nurhasim, A., Hidayana, I., Widyastuti, W., Oktavia, D., Adrian, V., Salama, N., Hamdi, I., Andrianto, A., Lina, R., Lestari, K. D., Shankar, A. H., Hamers, R. L., Thwaites, G., Baird, J. K.
10.1101/2020.12.14.20248159 — Posted: 2020-12-14
Association of Mortality and Aspirin Prescription for COVID-19 Patients at the Veterans Health Administration
Osborne, T. F., Veigulis, Z. P., Arreola, D. M., Mahajan, S. M., Roosli, E. M., Curtin, C. M.
10.1101/2020.12.13.20248147 — Posted: 2020-12-14
COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact
Swan, D. A., Bracis, C., Janes, H., Moore, M., Matrajt, L., Reeves, D. B., Burns, E., Donnell, D., Cohen, M. S., Schiffer, J., Dimitrov, D. T.
10.1101/2020.12.13.20248142 — Posted: 2020-12-14 Discussion: Onsite
SARS-CoV-2 among migrants and forcibly displaced populations: a rapid systematic review
Hintermeier, M., Gencer, H., Kajikhina, K., Rohleder, S., Santos-Hoevener, C., Tallarek, M., Spallek, J., Bozorgmehr, K.
10.1101/2020.12.14.20248152 — Posted: 2020-12-14
Identifying Synergistic Interventions to Address COVID-19 Using a Large Scale Agent-Based Model
Giabbanelli, P. J., Li, J.
10.1101/2020.12.11.20247825 — Posted: 2020-12-14

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).